Insider Buying: Phillip Md Et Al Frost Buys 8,200 Shares of Opko Health Stock (OPK)
Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost acquired 8,200 shares of Opko Health stock on the open market in a transaction dated Friday, January 10th. The stock was purchased at an average cost of $8.59 per share, with a total value of $70,438.00. Following the transaction, the chief executive officer now directly owns 1,987,500 shares of the company’s stock, valued at approximately $17,072,625. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.
Shares of Opko Health (NYSE:OPK) traded up 1.97% during mid-day trading on Monday, hitting $8.80. 5,038,268 shares of the company’s stock traded hands. Opko Health has a 1-year low of $5.30 and a 1-year high of $12.95. The stock’s 50-day moving average is $9.43 and its 200-day moving average is $8.97. The company’s market cap is $3.590 billion.
A number of analysts have recently weighed in on OPK shares. Analysts at Barrington Research raised their price target on shares of Opko Health to $11.00 in a research note to investors on Friday, December 20th. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Opko Health in a research note to investors on Wednesday, December 18th. Finally, analysts at Jefferies Group raised their price target on shares of Opko Health from $10.00 to $11.50 in a research note to investors on Wednesday, November 13th. They now have a “buy” rating on the stock.
OPKO Health, Inc (NYSE:OPK), incorporated in October 1991, is a multi-national pharmaceutical and diagnostics company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.